Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209462) titled 'Study of MRM-3379 in Male Participants With Fragile X Syndrome' on Oct. 2. St... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209501) titled 'Evaluating the Feasibility and Acceptability of Inhalation Aromatherapy for Pa... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07204977) titled 'Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Scl... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07207369) titled 'A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in ... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07207408) titled 'Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to ... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209488) titled 'Acquired Dyslexia Modeling and Treatment' on Oct. 2. Study Type: Intervention... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07211438) titled 'Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07211464) titled 'Acceptance and Commitment Therapy Plus Exercise for Older People With Chronic ... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07211490) titled 'rTMS for Cerebellar Ataxia in Children' on Oct. 2. Study Type: Interventional... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07207395) titled 'A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizu... Read More